← ANALYSTS · TIPRANKS
Michael Okunewitch · Maxim Group
Hits
36%
111 of 308 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
−3.3%
Over a year after the rating, TipRanks’ measure
Our companies rated now
8
Buy / hold / sell: 8 / 0 / 0
Upside of the analyst’s targets
+342.3%
Average over 8 current targets, to the last price
The market’s answer to the ratings
+2.7%
Day-0 move against SPY in the rating’s direction, average over 1 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Sep 16on TipRanks 13:45 | OCGNIWMOcugen · $276M | Reiterated | Buy | $8.00 | +925.6% | +0.9%next day +2.1% · 5 days −1.9% | ↗ |
| Sep 15on TipRanks Sep 16 07:55 | DFTXIWMDefinium Therapeutics · $4.6B | Reiterated | Buy | $55.00 | +71.3% | −8.1%next day +3.2% · 5 days +7.1% | ↗ |
| Aug 20on TipRanks Aug 24 02:55 | RANIRani Therapeutics Holdings · $113M | Reiterated | Buy | $5.00 | +681.2% | −6.3%next day +3.0% · 5 days −0.8% | ↗ |
| Aug 14on TipRanks Aug 15 14:25 | BLTEBelite Bio, Inc. ADR · $6.1B | Reiterated | Buy | $200 | +40.1% | −1.9%next day +0.7% · 5 days +0.3% | ↗ |
| Aug 14on TipRanks Aug 15 14:15 | MDWDIWMMediwound · $158M | Reiterated | Buy | $30.00 | +153.2% | +0.4%next day −0.8% · 5 days −1.2% | ↗ |
| Aug 11on TipRanks Aug 12 15:05 | LCTXIWMLineage Therap · $232M | Reiterated | Buy | $3.00 | +206.7% | −0.6%next day −2.0% · 5 days −5.0% | ↗ |
| Aug 6on TipRanks Aug 7 18:05 | GILDQQQSPYGilead Sciences · $195B | Reiterated | Buy | $165 | +5.6% | −0.5%next day +1.2% · 5 days +4.4% | ↗ |
| Apr 9on TipRanks Apr 8 15:25 | NGENNervGen Pharma · $205M | Assigned | Buy | $10.00 → $12.00+20.0% | +654.7% | +2.7%next day +0.1% · 5 days −2.1% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗